Drgem

At a glance

Drgem filed 14 disclosures in the last 12 months, including 1 contract. The most recent key filing was on Jul 22: Worth 18.7% of last year's revenue, over about 5 months.

Revenue for 2025 was ₩103B, down 1.2% on 2024. Operating margin was 8.8% against 8.5% a year earlier. Debt was 32% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩57.2B and operating profit of ₩6.2B.

The 2025 annual report lists 276 employees with an average tenure of 4.4 years and average pay of ₩57.1M, #1316 of 2,191 listed companies by average pay. Its 5 directors and auditors were paid ₩243M each on average. It paid ₩178 per common share in cash dividends, against ₩160 a year earlier (+11.3%). 박정병 and related parties held 41.08% at year end.

From the 2025 annual report

Staff: 276 (217 men, 59 women), of whom 5 on fixed-term contracts. Total pay for the year: ₩15.8B. Directors and auditors: 5, paid ₩1.2B in total.

Dividends (common shares)

Largest shareholder

박정병 holds 30.92%; with 9 related parties the group holds 41.08% of common shares at year end (from 41.09% at the start of the year).

Auditor: 삼화회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

New contracts, last 12 months

1 new supply contract worth 19% of the revenue stated in the filings.

Amended amounts replace the originals. Subsidiary contracts and terminations are excluded.

Financial summary